Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

73°
- Benton, AR (72018)
  Today
  
  Considerable cloudiness. High 76F. Winds SE at 5 to 10 mph..
  
  Tonight
  
  Partly to mostly cloudy. Low around 65F. Winds S at 5 to 10 mph.
  
  Updated: November 17, 2025 @ 2:51 pm
- Full Forecast

- Site search

Home
News
- Local News
Sports
Obituaries
Multimedia
- Photo Galleries
- Videos
e-Edition
Classifieds
Archives
Readers Choice 2025

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

(OP:NUMIF)

0.0303 -0.0062 (-16.99%)

Streaming Delayed Price Updated: 3:29 PM EST, Nov 17, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about NUMIF

< Previous 1 2 3 4 5 6 7 8 9 Next >

Only One Cannabis Stock Category Is Up So Far In June ↗

June 12, 2022

The cannabis sector consists of 5 distinct categories and they have each performed quite differently so far in June and YTD; 4 are down in June and all have dropped substantially YTD.

Via Talk Markets

Psychedelic Stock Gainers And Losers From June 10, 2022 ↗

June 10, 2022

GAINERS: Cybin (AMEX:CYBN) shares closed up 6.16% at $0.67

Via Benzinga

New Acquisition: Novamind To Buy Common Shares Of Numinus Pending Canadian Supreme Court Approval ↗

June 09, 2022

Numinus Wellness Inc.

Via Benzinga

Numinus' Ongoing Collaboration With Health Canada Spurs Mindspace Clinic Approval In Quebec ↗

May 24, 2022

A longstanding commitment of Numinus Wellness Inc. (OTC: NUMIF) to collaborate with Health Canada to help shape protocols for the Special Access Program appears to be paying dividends.

Via Benzinga

3 of 5 Cannabis Categories Declined During Third Week Of May ↗

May 22, 2022

The cannabis sector consists of 5 distinct categories and they each performed quite differently from each other during the third week of May.

Via Talk Markets

Numinus to Acquire Novamind For $20.74M In Stock ↗

April 12, 2022

Via Benzinga

Psyched: Compass, Atai And MindMed Release Q1 Earnings, Phase 3 MDMA Trial Closer To Completion, Enveric Splits Into Two Companies ↗

May 17, 2022

The psychedelics space got a new glimpse at the financials of some of its heavy hitters with the release of earnings reports for the first quarter of 2022.

Via Benzinga

Numinus Granted Canada's Special Access Program For Magic Mushrooms To Treat Life-Threatening Conditions ↗

May 16, 2022

Numinus Wellness Inc (OTCQB: NUMIF) has been approved to use psilocybin-assisted therapy through Health Canada’s Special Access Program (SAP), marking the first instance in which Numinus will provide...

Via Benzinga

2 Of The 5 Cannabis Categories Advanced Slightly During Second Week Of May ↗

May 14, 2022

The cannabis sector consists of 5 distinct categories, each performing differently from the other. Here, the stock performances during the second week of May, YTD and from the 2021 peak.

Via Talk Markets

Novamind And Numinus Prepare For Acquisition, Both Companies Share Info Circulars To Shareholders ↗

May 11, 2022

June 8, 2022 marks a turning point for both Numinus (OTCQX: NUMIF) and Novamind (OTCQB: NVMDF).

Via Benzinga

Novamind To Offer Virtual Mental Health Therapy Sessions ↗

May 02, 2022

Novamind (OTCQB: NVMDF), which is to be acquired by Numinus Wellness (OTCMKTS: NUMIF), recently announced a collaboration with health coaching platform HealCommunit

Via Benzinga

Numinus Wellness Strives To Become Psychedelic Research Hub After Acquisition Of Novamind Inc. ↗

April 13, 2022

In a year where M&A activity is expected to ratchet-up in 2022, Numinus Wellness Inc. (OTC: NUMIF) is among the first to take action.

Via Benzinga

Psyched: Atai, MindMed, Enveric and Mydecine Release 2021 Earnings, Bienstar Expands To Brazil & More! ↗

April 06, 2022

It’s earnings week in the psychedelics space, opening a new window into the financial situations of many companies in the sector.

Via Benzinga

March Update: Psychedelic Compounds-Based Drug Stocks Index Went Down -19% ↗

April 01, 2022

An update on the revisions that have been made to the Pure-Play Psychedelic Compounds-Based Drug Stocks Index with the increase in the minimum market capitalization required to be included in the...

Via Talk Markets

Numinus Administers MDMA To First Volunteer In Clinical Trial Sponsored By MAPS ↗

March 30, 2022

Numinus Wellness Inc. (OTCQX: NUMIF), announced that clinical trial MAPPUSX has gotten underwaywith the enrolling and dosing ...

Via Benzinga

Psychedelic Compounds-Based Drug Stocks Down Slightly This Past Week ↗

March 27, 2022

We're tracking 13 public companies (US and/or Canada) doing clinical-stage research into THC and/or psychedelics for treating mental illnesses. While a few were up this week, the overall trend...

Via Talk Markets

Cannabis Movers & Shakers: TGOD, Numinus Wellness, GTI, Neptune Wellness ↗

February 18, 2022

The Green Organic Dutchman Names New CFO The Green Organic Dutchman Holdings Ltd. (CSE:

Via Benzinga

Benzinga's Unprecedented Psychedelics Investing Conference Lands In Miami On April 19th ↗

February 09, 2022

The first Benzinga Psychedelics Capital Conference, the premier gathering of psychedelics industry leaders and forward-thinking investors, is coming to the Fontainebleau Miami Beach on April 19, 2022,...

Via Benzinga

Psyched: Psychedelics ETF Launches On NYSE, Psilocybin Trial Approved For Depression, DMT Study Begins ↗

February 07, 2022

This week saw new triumphs for public companies in the psychedelics space with the creation of a new ETF tracking the sector, which went public in the NYSE.

Via Benzinga

Psychedelic Stocks Finally In An Upswing ↗

February 06, 2022

The Marijuana & Psychedelic Compounds-Based Drug Stocks Index went up +5.3% last week.

Via Talk Markets

Psychedelics Co. Numinus Wellness Appoints New Bioscience Advisors To Bolster IP Development ↗

February 01, 2022

Psychedelics-focused company Numinus Wellness Inc. (TSX:NUMI) (OTCQX: NUMIF) announced the appointment of three key advisors to its new Bioscience Advisory Board.

Via Benzinga

The Psychedelic & Marijuana Drug Stocks Index Dropped -30% In January ↗

January 30, 2022

This article updates the performances of 16 clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses.

Via Talk Markets

Psyched: Eleusis To Go Public Via Merger, New Psychedelics Bills In Utah, Virginia, Kansas And Missouri ↗

January 24, 2022

Psychedelics Legalization Gains Momentum Around The Country: Bills Introduced In Utah, Virginia, Kansas And Missouri A wave of psychede...

Via Benzinga

Weekend Update: Only 2 Psychedelic Drug Stocks Are Up YTD ↗

January 23, 2022

This article updates the performances of the 16 largest capitalized clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses out of a...

Via Talk Markets

Numinus Wellness Reveals 244.5% YoY Improvement In Q1 Revenue & Wider Loss ↗

January 21, 2022

Numinus Wellness Inc (TSX:NUMI) (OTC:

Via Benzinga

Marijuana & Psychedelic Drug Stocks Continue To Decline ↗

January 16, 2022

The Marijuana & Psychedelic Compounds-Based Drug Stocks Index consists of 16 of the 100 such companies that trade on North American stock exchanges. 5 of them are marijuana drug stocks and 11 are...

Via Talk Markets

Pure-Play Marijuana- & Psychedelic Compounds-Based Drug Stocks Index Is Down By 66% From 2021 High ↗

January 09, 2022

There are 16 remaining constituents of our Marijuana & Psychedelic Compounds-Based Drug Stocks Index is now DOWN -65.9% from its highs in 2021. Here are the details for each of its constituents.

Via Talk Markets

Steep Decline In Cannabis & Psychedelic Compounds-Based Drug Stocks Continues: DOWN -16.6% MTD ↗

December 24, 2021

All 12 constituents in the Marijuana & Psychedelic Compounds-Based Drug Stocks Index continue to decline. How do their performances compare month-to-date and YTD?

Via Talk Markets

The Year In Review For Psychedelic Drug Stocks: 2021 ↗

December 21, 2021

2021 was two different

Via Talk Markets

Psychedelics Company Numinus Wellness Q4 Revenue Grows 81% YoY Thanks To Mindscape Acquisition ↗

December 10, 2021

Psychedelics-focused mental health care company Numinus Wellness Inc. (TSXV:

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Entertainment
Local Events
Obituaries
Multimedia
Announcements
e-Edition
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

bentoncourier.com
321 North Market Street
Benton, AR 72018
Phone: 501-315-8228
Email: bcadmin@bentoncourier.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Benton, AR (72018)

Today

Tonight

(OP:NUMIF)

Headline News about NUMIF

Sections

Services

Follow Us